1. Kuehn Law is investigating HIMS officers for fiduciary duty breaches. 2. Insiders allegedly misrepresented the promotion of illegitimate Wegovy versions. 3. Concerns raised about potential termination of collaboration with Novo Nordisk. 4. Positive statements about HIMS's operations were deemed materially misleading. 5. Shareholders are being encouraged to join the lawsuit against HIMS.
Historical instances show lawsuits can negatively affect stock prices significantly; similar previous cases led to sharp declines.
Given the serious allegations and the potential financial impact, this article is highly relevant to HIMS.
Immediate legal challenges often lead to rapid stock price reactions and investor sentiment shifts.
NEW YORK, Sept. 24, 2025 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Hims & Hers Health, Inc. (NYSE:HIMS) breached their fiduciary duties to shareholders.
According to a federal securities lawsuit, Insiders at Hims & Hers Health caused the company to misrepresent or fail to disclose that (1) that Hims was engaged in the "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy that put patient safety at risk;" (2) that, as a result, there was a substantial risk that the Company's collaboration with Novo Nordisk would be terminated; and (3) that, as a result of the foregoing, positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you currently own HIMS and purchased prior to April 29, 2025 please contact Justin Kuehn, Esq. here, by email at justin@kuehn.law or call (833) 672-0814. Kuehn Law pays all case costs and does not charge its investor clients. Shareholders should contact the firm immediately as there may be limited time to enforce your rights.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
For additional information, please visit Shareholder Derivative Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
View original content to download multimedia:https://www.prnewswire.com/news-releases/kuehn-law-encourages-investors-of-hims--hers-health-inc-to-contact-law-firm-302566064.html
SOURCE Kuehn Law, PLLC